Galmed Pharmaceuticals Ltd. (GLMD)
NASDAQ: GLMD · Real-Time Price · USD
0.5735
0.00 (0.00%)
At close: Jun 26, 2026, 4:00 PM EDT
0.5453
-0.0282 (-4.92%)
After-hours: Jun 26, 2026, 7:20 PM EDT
Galmed Pharmaceuticals Market Cap
Galmed Pharmaceuticals has a market cap or net worth of $3.77 million as of June 26, 2026. Its market cap has decreased by -0.67% in one year.
Market Cap
3.77M
Enterprise Value
-14.38M
1-Year Change
-0.67%
Ranking
Category
Stock Price
$0.57
Market Cap Chart
Since March 13, 2014, Galmed Pharmaceuticals's market cap has decreased from $145.70M to $3.77M, a decrease of -97.41%. That is a compound annual growth rate of -25.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 3.80M | -7.32% |
| Dec 31, 2025 | 4.10M | -14.58% |
| Dec 31, 2024 | 4.80M | 166.67% |
| Dec 29, 2023 | 1.80M | -85.71% |
| Dec 30, 2022 | 12.60M | -72.43% |
| Dec 31, 2021 | 45.70M | -30.44% |
| Dec 31, 2020 | 65.70M | -45.93% |
| Dec 31, 2019 | 121.50M | 23.23% |
| Dec 31, 2018 | 98.60M | -11.33% |
| Dec 29, 2017 | 111.20M | 185.13% |
| Dec 30, 2016 | 39.00M | -53.85% |
| Dec 31, 2015 | 84.50M | 42.98% |
| Dec 31, 2014 | 59.10M | -59.44% |
| Mar 13, 2014 | 145.70M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Evogene | 4.21M |
| Ensysce Biosciences | 4.16M |
| Artelo Biosciences | 4.04M |
| Matinas BioPharma Holdings | 3.99M |
| FibroBiologics | 3.96M |
| Revelation Biosciences | 3.75M |
| Clearmind Medicine | 3.70M |
| Onconetix | 3.62M |